1. Home
  2. FULT vs ADMA Comparison

FULT vs ADMA Comparison

Compare FULT & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulton Financial Corporation

FULT

Fulton Financial Corporation

HOLD

Current Price

$20.74

Market Cap

3.5B

Sector

Finance

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$9.26

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FULT
ADMA
Founded
1882
2004
Country
United States
United States
Employees
3400
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.6B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
FULT
ADMA
Price
$20.74
$9.26
Analyst Decision
Hold
Buy
Analyst Count
5
2
Target Price
$21.40
$32.00
AVG Volume (30 Days)
2.1M
8.8M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
3.66%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.60
Revenue
N/A
$42,219,783.00
Revenue This Year
$6.39
$27.46
Revenue Next Year
$5.52
$22.11
P/E Ratio
$10.58
$15.48
Revenue Growth
N/A
43.85
52 Week Low
$14.70
$7.21
52 Week High
$22.99
$25.67

Technical Indicators

Market Signals
Indicator
FULT
ADMA
Relative Strength Index (RSI) 57.07 25.88
Support Level $19.05 $7.21
Resistance Level $21.01 $16.44
Average True Range (ATR) 0.48 1.07
MACD 0.16 -0.23
Stochastic Oscillator 91.78 23.31

Price Performance

Historical Comparison
FULT
ADMA

About FULT Fulton Financial Corporation

Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: